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Abstract – Selection for disease resistance related traits is a tool of choice for evidencing and
exploring genetic variability and studying underlying resistance mechanisms. In this frame-
work, chickens originating from a base population, homozygote for the B19 major histocompat-
ibility complex (MHC) were divergently selected for either progression or regression of tumors
induced at 4 weeks of age by a SR-D strain of Rous sarcoma virus (RSV). The ﬁrst generation
of selection was based on a progeny test and subsequent selections were performed on full-sibs.
Data of 18 generations including a total of 2010 birds measured were analyzed for the tumor
proﬁle index (TPI), a synthetic criterion of resistance derived from recording the volume of
the tumors and mortality. Response to selection and heritability of TPI were estimated using a
restricted maximum likelihood method with an animal model. Signiﬁcant progress was shown
in both directions: the lines diﬀering signiﬁcantly for TPI and mortality becoming null in the
“regressor” line. Heritability of TPI was estimated as 0.49 ± 0.05 and 0.53 ± 0.06 within the
progressor and regressor lines respectively, and 0.46 ± 0.03 when estimated over lines. Prelim-
inary results showed within the progressor line a possible association between one Rfp-Y type
and the growth of tumors.
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1. INTRODUCTION
For the analysis of genetic control of health traits in domestic animals, there
is a growing interest for selection experiments as a powerful tool to explore the
genetic variability of these traits and to create extreme phenotypes allowing
the analysis of underlying mechanisms and the search for new genetic mark-
ers of disease resistance traits. Such tools are particularly developed in the
chicken for the analysis of immunoresponsiveness [31] or resistance to spe-
ciﬁc diseases [3]. Resistance to viral diseases are examples of traits for which
a genetic basis has been shown in many animal species [36]. For instance, se-
lection for resistance to Marek’s disease is one of the ﬁrst successful selection
experiments in chickens [9].
Resistance to another type of avian viral disease, the Rous Sarcoma virus
(RSV), has been widely studied. Resistance to this disease is highly interest-
ing as a model of resistance to tumor growth and its study has allowed new
ﬁndings on related mechanisms and the genes involved. Indeed, early studies
on RSV stipulated that only a very restricted number of genes and even one
single gene would be involved in the control of tumor regression or progres-
sion. This was in some cases because of the easiness to select for the trait or
because of the observation of the segregation of diﬀerent phenotypes [21] or
because of the particular genetic background of some inbred lines used inten-
sively for the study of the fate of RSV tumors [10, 33, 39]. Naturally, most
of the studies on RSV tumor control consider MHC as the natural candidate
of choice as far as disease resistance is concerned, and showed an eﬀect of
the avian B-complex on either the progression or regression, as reviewed by
Schierman and Collins [38]. Some major diﬀerences between genotypes in
a given background have often been shown. For example, in an F2 cross of
two highly inbred lines homozygous for B2 and B5, the most resistant geno-
type (B2B2) showed 5% of mortality and a mean Tumor Proﬁle Index (TPI) of
2.94 and the most susceptible genotype (B5B5) showed a 93% mortality and a
mean TPI of 4.93 whereas the heterozygote showed values closer to the resis-
tant genotype than to the susceptible one [10]. Even ifall the studies performed
were not able to distinguish a possible direct eﬀect from a closely linked eﬀect,
some clearly proved, using several recombinants in diﬀerent backgrounds, that
the genetic control is associated with the B−F/B−L region rather than with
the B−G one [1,2,33]. Most reports studying the eﬀect of MHC on the fate
of RSV tumors were conducted from comparisons between congenic inbred
lines or crosses between inbred lines, the possible amount of genetic variabil-
ity expressed. Some of these studies, however, allowed at the same time to
show evidence for non-MHC variation in the control of tumor fate when ge-
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from three partially congenic inbred lines, Cutting et al. [14] and Plachy [32]
showed that resistance to RSV is the result of complementing action of MHC
(or MHC-linked) genes and genes outside the MHC. The frequency of regres-
sor chickens observed in the backcross mating and hybrids corresponded to
the expected frequency of birds heterozygous for allelic genes at two indepen-
dent loci. Indeed, the eﬀect of non-MHC genes has been shown to be critical
for regression of Rous sarcoma [7] using similar or identical MHC haplotypes
in diﬀerent genetic backgrounds and the relative inﬂuence of MHC and non-
MHC genes was evaluated by Gebriel and Nordskog [16].
In this context, the selection experiment analysed hereafter was set up with
animals which were all serologically deﬁned homozygous for BG19 [15]. The
selection would therefore explore MHC polymorphism outside the BG region
and all the non-MHC variation. The aim of the study was to analyze 18 genera-
tions of selection for either progression or regression of RSV induced tumors,
to estimate genetic parameters of one resistance trait (TPI) and to present a
preliminary result on the association between the fate of the tumor and Rfp-Y
types, the second MHC gene polymorphic cluster in the chicken outside the
B-complex [5].
2. MATERIALS AND METHODS
2.1. Selection lines
A divergent selection for resistance to Rous sarcoma virus was initiated
in 1982 from a White Leghorn base population (generation G0) for 18 gen-
erations. The chicken line was bred at the Domaine du Magneraud (Inra,
France) in speciﬁed pathogen-free conditions. A serological survey of breeder
stocks was performed to ascertain the absence of speciﬁed pathogens includ-
ing Marek’s disease virus, avian leucosis virus, Newcastle disease virus, Gum-
boro disease virus, reovirus, infectious bronchitis disease virus, adenovirus,
pseudoadenovirus, salmonella pullorum and gallinarum, mycoplasma gallisep-
ticum and synoviae. Challenges were performed in ﬁltered-air negative-
pressure rooms at the Station de pathologie aviaire et parasitologie at Nouzilly
(Inra, France).
The ﬁrst generation of selection was performed by a progeny test. Progeny
was inoculated in the subcutaneous tissue of the wing web at 4 weeks of age
with 1000 focus-forming units per bird of a Rous Sarcoma virus strain D
identiﬁed as the Schmidt-Ruppin strain of subgroup D (provided by P. Vigier,
Institut Curie, France). The volume of the tumors was calculated 10 days post
inoculation (PI) from the three maximum dimensions of the tumor using a slide
calliper. Then the volumes were recorded every three days for one month. The
means of the maximum volume of the tumor scored at any time during this68 M.-H. Pinard-van der Laan et al.
period were calculated for each sire progeny. Sires producing the upper third
and lower third of this mean distribution were assigned as “progressor” and
“regressor”, respectively. Dams were selected on the basis of their divergence
to sires, i.e., dams whose progeny showed a higher or lower mean of the max-
imum volume of tumors than the sire family were classiﬁed as progressor or
regressor, respectively. At this step, 7 sires and 21 dams (hatched in 1982 and
originating from 3 males and 8 females) and 7 sires and 21 dams (hatched in
1982 and originating from 3 males and 6 females) were selected and assigned
as “progressor” and “regressor”, respectively.
Subsequent selections, from G1 to G18, were based on full-sib family per-
formances, carrying out the same protocol of the Schmidt-Ruppin strain virus
challenge and according to the same selection criterion, i.e., maximum volume
of tumors. The numbers of animals tested are given in Table I. One generation
was produced per year, except in 1989, 1993 and 1995 where two generations
were hatched. In years 1986, 1987 and 1989, no selection was performed due
to the occurrence of positive serology to the Marek’s disease virus. The tested
animals were produced in one hatch, except in 1982, 1984 and 1991 and in
1983, where two and three hatches were produced, respectively.
From G10 onwards, the animals were selected still on full-sibs but repro-
duced within separate sublines in each line. Four sublines were derived in the
regressor line, called pe5, pe10, pe11 and pe58. Seven sublines were derived
in the progressor line, called pd2, pd4, pd5, pd8, pd10, pd1317 and pd1321.
These sublines were produced and tested in balanced size.
2.2. Recorded resistance traits: TPI, mortality, time of death
From G1 onwards, the animals were inoculated and tested as previously
described. Only, the length of the experiment may vary. For all generations,
tumor size was recorded every week from 7 to 63 days PI. In addition, the an-
imals from G6, G16 and G18 were measured until 70 days PI and the animals
from G1, G2 and G3 were measured until 99, 126 and 105 days PI, respec-
tively. Mortality was recorded daily. From the observation of the volume of
the tumor and mortality, two classical criteria were deﬁned: score and tumor
proﬁle index. Scores were deﬁned weekly as follows: 0 = no palpable tumor;
1 = t u m o ru pt o1c m 3;2= tumor between 1 and 5 cm3;3= tumor between
5 and 25 cm3;4= tumor between 25 and 50 cm3;5= tumor between 50 and
100 cm3;6= tumor over 100 cm3;7= death during the experiment. The
scores were used to assign a tumor proﬁle index (TPI) as slightly modiﬁed
from Collins et al. [10]: 5 = a terminal tumor at 35 days PI; 4 = terminal
t u m o ra t4 9d a y sP I ;3= terminal tumor at 63 days PI; 2 = t u m o ru pt o1c m 3;
1 = otherwise (tumor less than 1 cm3 , no tumor or complete regression by the
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In this study, besides mortality and age at death, TPI was only analyzed
since it is the most synthetic criterion describing the resistance to the Rous sar-
coma virus. The detailed analysis of tumor growth of this selection experiment
will be the subject of another study.
2.3. Typing for MHC and Rfp-Y
Reﬁned analysis and characterization of Rfp-Y types are described by Tho-
raval et al. [40]. Brieﬂy, all animals of the progressor and regressor lines
were serologically typed for the B-complex as homozygous BG19. In addition,
RFLPtyping showed no polymorphism for class IV types but diﬀerent patterns
using class I and class II probes [8]. The relationship to polymorphism for the
Rfp-Y system was further assessed, revealing three diﬀerent Rfp-Y haplotypes:
Yw*15, Yw*16 and Yw*17. These assignments are tentative since suﬃcient care-
ful comparisons remain to be done.
2.4. Statistical analysis
A comparison between lines when performed for a given generation were
done, with a t-test for continuous traits, after checking for normality with the
UNIVARIATE procedure. Frequency values were compared with a chi square
test. The eﬀects of Rfp-Y types on mortality were estimated using the CAT-
MOD procedure. The eﬀect of hatch, when applicable, was tested on TPI and
mortality and was found non signiﬁcant and therefore not included in further
analyses. All these tests were performed using the SAS    library [34,35].
The heritability of the selected TPI was obtained by using VCE soft-
ware [20], applying the derivative-free restricted maximum likelihood method
(DFREML)of Meyer [30], according to the following individual animal model
(IAM):
TPIjkm = µ + Gj + Sk + Ujkm + ejkm (1)
where TPIjkm = the TPI of the mth chick;
µ = a constant;
Gj = the ﬁxed eﬀect of the jth generation (0 to 18);
Sk = the ﬁxed eﬀect of the kth sex of the chick;
Ujkm = the random additive genetic eﬀect on the TPI in the mth chick
and ejkm = a random error.
All relationships of the eighteen generations and data from all generations
measured during this period were used (Tab. I). The ﬁxed eﬀect of the gen-
eration accounted for diﬀerences in environmental and experimental condi-
tions between generations. Heritability for TPI was estimated across lines and
within both selected lines. Individual inbreeding coeﬃcients were estimated
using the method of Meuwissen and Luo [29] using the PEDIG software [4].70 M.-H. Pinard-van der Laan et al.
Table I. Number of animals measured, data recorded and Rfp-Y type analysed, per
line and generation.
Line
Year G1 P2 R3 TPI4 Rfp-Y type5
82 0 262 X6 ND7
83 1 157 155 X ND
84 2 158 146 X ND
85 3 96 84 X ND
86 4 . . ND ND
87 5 . . ND ND
88 6 19 38 X ND
89a 7 . . ND ND
89d 8 . . ND ND
90 9 53 49 X X
91 10 83 47 X X
92 11 69 49 X X
93a 12 32 34 X X
93d 13 55 35 X X
94 14 59 41 X X
95a 15 45 27 X X
95d 16 42 27 X X
96 17 48 24 X X
97 18 52 24 X X
1Generation n; 2numbers of animals recorded in the progressor (P) line; 3numbers of animals
recorded in the regressor (R) line; 4tumor proﬁle index (TPI) recorded (X6) or not done (ND7);
5Rfp-Y type analysed (X6) or not done (ND7).
The average inbreeding level of each line was then calculated per generation.
Estimated breeding values (EBV) for TPI were estimated with the PEST soft-
ware [19] by applying model 1 and using the heritability value estimated by
VCE. The selection response was evaluated by averaging these EBV per line
and generation.
The eﬀects of Rfp-Y type on TPI were separately estimated in the selected
lines, using the following model:
TPIjklm = µ + Gj + Sk + Rfp-Yl + Ujklm + ejklm (2)Selection for resistance to Rous sarcoma 71
Table II. LSMean values (± SE) for the tumor proﬁle index (TPI) and time of death
(d), andmortality(%)in the progressor(P)andregressor(R) line, in thegenerations1,
14 and 18.
N.B. Meansare presentedfor the ﬁrst and last generations(1 and 18, respectively)and
at the maximum of response (14).
Generation
11 4 1 8
Line
Trait P R P R P R
TPI 2.84±0.08a 2.04±0.08b 3.45±0.13a 1.11±0.16b 1.91±0.14a 1.22±0.21b
Mortality (%) 66.24a 35.48b 74.58a 0.00b 25.00a 0.00b
Time of death (d) 49.52±1.77a 56.23±2.30b 34.15±2.40 . 55.82±4.41 .
a,b Values with diﬀerent superscripts indicate diﬀerences (P < 0.01) between lines within
generation.
where Rfp-Yl = the ﬁxed eﬀect of the lth Rfp-Y type and all the other terms
are as deﬁned in model (1). The solutions were obtained using the PEST pro-
gram and the heritability values estimated previously in the lines. Diﬀerences
between Rfp-Y types were tested as contrasts by a F-value generated by PEST.
3. RESULTS
3.1. Phenotypic selection response for TPI
Phenotypic responses to selection for TPI during 18 generations expressed
as the mean TPI per line and generation is shown in Figure 1. A signiﬁcant
diﬀerence of 0.8 TPIwas obtained already after the ﬁrst generation of selection
between the progressor and regressor line (Tab. II). The signiﬁcance of the
TPI diﬀerence between the lines remained unstable until generation 10. From
generation 11 onwards, the lines diﬀered signiﬁcantly for TPIwith a maximum
diﬀerence of 2.34 in generation 14, the progressor line reaching its highest
value during the selection at 3.45 TPI (Tab. II).
3.2. Phenotypic selection response for mortality and time of death
Mortality in the progressor and regressor lines showed very similar evo-
lution as presented for the TPI in Figure 1 (data not shown). A signiﬁcant
diﬀerence in mortality of 30.76% was observed between the lines at genera-
tion 1 (Tab. II). The diﬀerence remained signiﬁcant (P < 0.01) during the
whole selection except in generation 9. The diﬀerence was maximum in gen-
eration 14 with 74.58% and 0% mortality for the progressor and regressor
lines, respectively and tended to decrease afterwards. From this generation72 M.-H. Pinard-van der Laan et al.
Figure1. Phenotypicresponseforthetumorproﬁleindex(TPI)intheregressor(Reg)
andprogressor(Prog)linesduring18generations. “*”indicatesdiﬀerences(P < 0.01)
in mean TPI between the lines for a given generation. “ns” indicates no signiﬁcant
diﬀerence.
14 onwards, mortality was null in the regressor line. Average time at death
was compared when relevant between progressor and regressor lines (Tab. II).
After the ﬁrst and third generations, the birds from the progressor line died
signiﬁcantly (P < 0.01) earlier than did those from the regressor line. After-
wards, there was no clear diﬀerence for the time of death between the lines nor
for its direction nor signiﬁcance.
3.3. Inbreeding of the lines
The evolution of the average inbreeding level was similar for the progressor
and regressor lines. Inbreeding increased in a linear way of about +3.51% per
generation and reached after 18 generations high levels of 66.54% and 61.06%
in the progressor and regressor lines, respectively.
3.4. Heritability of the TPI
The heritability of the Tumor Proﬁle Index, estimated using all data and
pedigree information on all lines over 18 generations, was 0.46 ± 0.03. When
estimated in selected lines separately, the analyses gave similar values in the
progressor line (0.49 ± 0.05) and in the regressor line (0.53 ± 0.06).Selection for resistance to Rous sarcoma 73
3.5. Genetic selection response for TPI
3.5.1. In progressor and regressor selected lines
The evolution per line and generation of the mean of the breeding values for
the TPI estimated using all data and pedigree information is shown in Figure 2.
The diﬀerence between the progressor and regressor lines remained signiﬁcant
although the importance of the divergence between the lines varied widely
during the course of the selection. Three phases may be seen with the lines
diverging from each other before becoming closer in terms of genetic values:
generations 0-3, 3-8 and 8-18. The second phase (3-8) corresponds to a period
where only one generation of selection could be actually performed (genera-
tion 6). As observed for phenotypic values, genetic divergence was maximum
at generation 14 (divergence of 1.75 estimated TPI) but diminished at the end
of the period analyzed here (divergence of 0.96 estimated TPI).
3.5.2. Within sublines of the progressor and regressor selected lines
Sincefrom generation 10onwards theanimals wereselected and bredwithin
separate sublines, the estimated breeding values for the TPI were averaged per
subline as well. In the regressor line, there were no large changes in the rank-
ing of the sublines during the last eight generations (data not shown). At gen-
eration 18, the pe10 regressor subline showed a signiﬁcantly higher genetic
value for the TPI than the other sublines (pe58, pe11 and pe5) (Tab. III). In
the progressor line, various trends were observed depending on the sublines
as shown in Figure 3. Finally, in generation 18, there were two signiﬁcantly
distinct groups within the progressor line with a higher progressor group (pd2,
pd1321, pd8 and pd1317) versus a lower progressor group (pd10, pd4 and pd5)
(Tab. III).
3.6. Generation eﬀect on the TPI
Generation eﬀects, estimated from model 1, showed large variations across
generations, with “favorable” generations like generations 1 (+0.6 TPI), 12
(+0.5 TPI) or 14 (+0.3 TPI) and “unfavorable” ones like the last three genera-
tions (−0.6 TPI).
3.7. Eﬀects of sex on TPI, mortality and time of death
Sex eﬀect was estimated on the TPI and time at death on the whole selec-
tion. For both criteria, females appeared more sensitive, showing a higher TPI
(+0.159 TPI) and dying earlier (−4.38 days) (P < 0.01).74 M.-H. Pinard-van der Laan et al.
Figure 2. Genetic response for the tumor proﬁle index (TPI) expressed as the mean
estimated breeding values (EBV) in the regressor (Reg) and progressor (Prog) lines
during 18 generations.
Figure 3. The mean estimated breeding values (EBV) for the tumor proﬁle index
(TPI) per subline in the progressor line from generations 10 to 18.
3.8. Eﬀects of Rfp-Y t y p e so nT P Ia n dt i m eo fd e a t h
Theeﬀects of Rfp-Y types were estimated on the TPIin both lines and on the
time of death in the progressor line from generations 9 to 18. The results are
shown per line in Table IV. The diﬀerent sublines of progressor and regressor
diﬀered in Rfp-Y types but the use of the IAM could take into account these
diﬀerences to estimate the Rfp-Y type. The eﬀect of Yw*15could not be esti-
mated in the regressor line because it was absent there. In the regressor line,Selection for resistance to Rous sarcoma 75
Table III. Least Square Means of estimated breeding values for tumor proﬁle index
(TPI) in the diﬀerent sublines of the regressor (R) and progressor (P) lines in genera-
tion 18.
Line
RP
Subline LSMean ± SE Subline LSMean ± SE
pe10 0.115 ± 0.055a pd2 1.298 ± 0.101a
pe58 −0.232 ± 0.055b pd1321 1.277 ± 0.109a
pe11 −0.327 ± 0.055b pd8 1.226 ± 0.109a
pe5 −0.339 ± 0.055b pd1317 1.216 ± 0.109a
pd10 0.476 ± 0.089b
pd4 0.349 ± 0.089b
pd5 0.103 ± 0.089b
a,b Estimates with diﬀerent superscripts indicate diﬀerences (P < 0.01) between sublines within
line.
Table IV. Estimates of Rfp-Y type eﬀect on the tumor proﬁle index (TPI) in the re-
gressor (R) and progressor (P) lines and on the time of death in the progressor (P) line
in the generations 9 to 18.
Trait
TPI Time of death (d)
Line
Rfp-Y type R P P
Yw*16 0.000a 0.000a 0.00a
Yw*17 0.047a −0.930b 5.55b
Yw*15 . −1.119b 8.11b
a,b,c Estimates with diﬀerent superscripts indicate diﬀerences (P < 0.01) between Rfp-Y types
within line.
there was no signiﬁcant eﬀect of the Rfp-Y type on TPI. In the progressor line,
the Yw*16 type was associated with a higher sensitivity, the animals showing a
higher TPI and dying earlier than the Yw*17 and Yw*15 carriers.
4. DISCUSSION
Divergent selection for progression and regression to RSV showed here a
rapid and successful response since after one generation, the two selected lines
diverged signiﬁcantly for TPI, mortality and age at death. A fast response to
selection for regression of tumors to a Bryan strain of RSV was ﬁrst reported76 M.-H. Pinard-van der Laan et al.
by Gyles and Brown [21], who used individual performances during the ﬁrst
three generations and a mixture of individual and full-sib family performances
later. Itagreed with aprevious assumption that the number of genes controlling
resistance to RSV would be limited [15]. The number of birds showing com-
plete regression increased from 14% in the base population to 59% after six
generations, which represented 30% more than in the genetic control line. In
the data presented here, the eﬀect of the selection in the following generations
may be questioned even more. Even if the phenotypic diﬀerences between the
progressor and the regressor lines were mostly signiﬁcant for TPI or mortality,
the end values in the progressor lines were less severe than in the ﬁrst, 12th
or 14th generations. Time of death did not show either any obvious correlated
response to selection but it should be analyzed more accurately, using dedi-
cated models. Selection in the regressor line was successful but likely limited
downwards in the last generations by this obligatory biological threshold of no
mortality nor tumor, without a ﬁner selection criterion. The assumption that in
the last generation, the regressor birds would no longer be able to be infected
due to a loss of receptors for ALV-D cannot be excluded either.
The genetic analysis of the selection using estimated breeding values from
an animal model provides a more accurate estimate of response to selection
since it takes into account all the numerous relationships between individuals.
Indeed the genetic trends obtained were smoother than the phenotypic ones,
showing more clearly the diﬀerent phases of selection but also showing obvi-
ously smaller diﬀerences between the lines than did the phenotypic means.
The values of heritability for TPI were rather high for a disease resistance
trait (0.46 overall lines) but in agreement with successful selections. The esti-
mates of heritabilities were equivalent in both lines in agreement with a rather
symmetric response to selection. Using other types of animal material (inbred
lines deriving from either noninbred progressor or regressor lines) and estima-
tion methods (sire component from least squares analysis), Gyles et al. [23]
found signiﬁcant additive genetic variation in the regression process but not in
the progression of tumors. Urban et al. [41] using a nested analysis of vari-
ance estimated a comparable value of heritability for TPI (0.41) in an outbred
line. In addition, these authors indicate the likely presence of dominance or
maternal eﬀects.
In the present study, females appeared more susceptible than males sug-
gesting interactions between the hormonal system and resistance mechanisms.
The eﬀects of sex are widely varying with the disease trait or the genetic back-
ground. In an F2 cross of B2B2 and B5B5 lines, Collins et al. [10] did not
show any eﬀect of sex on the fate of the RSV tumor. But Collins et al. [13] by
analysis of the metastasis later found that females display fewer disseminated
lesions than males. Gyles et al. [22] compared sexes within progressor andSelection for resistance to Rous sarcoma 77
regressor groups and found no diﬀerence in the progressor group but in the re-
gressive one, females showed higher scores, larger tumors and took more days
to regress.
The Rfp-Y system was recently found to be an independent system from the
B-complex [5], the diﬀerent subtypes identiﬁed previously using class I and
class II probes [8] being in fact Rfp-Y types. The studies on the association be-
tween the Rfp-Y system and resistance to diseases are scarce (e.g. resistance to
Marek’s disease [42,43]). LePage et al. [26] analysed the fate of RSV (Bryan
high-titer strain of subgroup A) tumors for three haplotypes combined into ﬁve
diﬀerent Rfp-Y genotypes obtained in a B2B5 background. A signiﬁcant eﬀect
of Rfp-Y on TPI and mortality was found, with large diﬀerences in mortal-
ity between the most resistant and the most susceptible genotype (14.3% and
72.2%, respectively) and for TPI (1.4 and 3.4, respectively). We found a sig-
niﬁcant but more moderate eﬀect of the Rfp-Y type on the TPI (diﬀerence of
1 TPI) in the progressor line. The absence of an eﬀect of Rfp-Y in the regressor
line could be due to an interaction with the genetic background or simply that
Rfp-Y genes did not play a major role in the coselection of regressor genes.
Indeed, the Yw*15 type disappeared in the regressor line although it was asso-
ciated with a low TPI in the progressor line. Moreover, despite using an animal
model, the results should be cautiously interpreted due to the speciﬁc family
structure (sublines bred separately in this typed phase) and high inbreeding.
Several segregating crosses to break linkage disequilibrium accumulated over
generations would be needed to accurately estimate all possible Rfp-Y geno-
types against a more random background. Even more interesting would be
to combine these diﬀerent Rfp-Y genotypes with diﬀerent B genotypes since
complementing eﬀects have been suggested by LePage et al. [26]. Also, as
found for the MHC, interactions between the eﬀect of the Rfp-Y system on
the fate of RSV tumors and other factors like age at inoculation [24], virus
strain [27] or dose of virus [37] should be investigated. Senseney et al. [37] in
a cross segregating for two haplotypes (BQ and B17) found no eﬀect of MHC
on the regression of tumors at a high dose of virus but an eﬀect at a lower dose
of the same virus and in the same genetic stock with an allelic complemen-
tation between the two alleles, the heterozygote state showing an advantage
towards tumor regression. The superiority of other heterozygote combination
were found elsewhere [6,27,39]. The eﬀect of the resistance genes may clearly
depend on the degree of pathogenicity of the virus.
This study opens ways to search for other genes controlling the fate of RSV
tumors. Other genetic systems have been reported as being associated with
the fate of tumors. Non-MHC alloantigens (Ea-L) aﬀected tumor size, TPI
and mortality depending on the MHC background [28] or not [25]. Non-MHC78 M.-H. Pinard-van der Laan et al.
T-lymphocyte and B-cells alloantigens were found to have an eﬀect on re-
gression, resulting from speciﬁc interactions between alleles and genetic back-
ground [17,18]. Also the endogenous viral genes have been found to be as-
sociated with progression or regression [32]. The current lines are segregating
for some of the ALVE genes and the role of ALVE1 is now being investigated.
Such divergent lines represent a powerful tool to look jointly for genes con-
trolling the fate of RSV tumors and underlying mechanisms. Tumor fate was
roughly analyzed by the TPI, the most synthetic criterion used so far. A ﬁner
analysis will consider the diﬀerent aspects of the growth of tumors. Also,
either the progression or regression of tumors involves complex and intricate
immune mechanisms. There are indications that some families in the current
lines may either show antiviral responses or antitumoral response. It will be
of high interest to discover whether the Rfp-Y system or the endogenous viral
genes might control these diﬀerent pathways.
REFERENCES
[1] Aeed P.A., Briles W.E., Zsigray R.M., Collins W.M., Inﬂuence of diﬀerent B-
complex recombinants on the outcome of Rous sarcomas in chickens, Anim.
Genet. 24 (1993) 177–181.
[2] Auclair B.W., Collins W.M., Zsigray R.M., Briles W.E., B-complex recombi-
nants and sarcoma regression: role of B-L/B-F region genes, Poult. Sci. 74
(1995) 434–440.
[3] Bacon L.D., Hunt H.D., Cheng H.H., A review of the development of chicken
lines to resolve genes determining resistance to diseases, Poult. Sci. 79 (2000)
1082–1093.
[4] Boichard D., PEDIG: a fortran package for pedigree analysis suited for large
populations, in: Proceedings of the 7th World Congress on Genetics Applied to
Livestock Production, August 19-23, 2002, INRA, Castanet Tolosan, CD-ROM
communication n◦ 28–13.
[5] Briles W.E., Goto R.M., Auﬀray C., Miller M.M., A polymorphicsystem related
to but genetically independent of the chicken major histocompatibility complex,
Immunogenetics37 (1993) 408–414.
[6] Brown D.W., Collins W.M., Ward P.H., Briles W.E., Complementation of ma-
jor histocompatibility haplotypes in regression of Rous sarcoma virus-induced
tumors in noninbred chickens, Poult. Sci. 61 (1982) 409–413.
[7] Brown D.W., Collins W.M., Zsigray R.M., Briles W.E., A non-MHC genetic
inﬂuence on response to Rous sarcoma virus-induced tumors in chickens, Avian
Dis. 28 (1984) 884–899.
[8] Chauss´ e A.M., Thoraval P., Coudert F., Auﬀray C., Dambrine G., Analysis of B
complexpolymorphismin Rous sarcomaprogressorand regressorchickenswith
B-G, B-F, and B-L beta probes, Avian Dis. 34 (1990) 934–940.Selection for resistance to Rous sarcoma 79
[9] ColeR.K.,StudiesongeneticresistancetoMarek’sdisease,AvianDis.12(1968)
9–28.
[10] Collins W.M., Briles R.W., Zsigray R.M., Dunlop W.R., Corbett A.C., Clark
K.K., Marks J.L., McGrail T.P., The B locus (MHC) in the chicken: association
with the fate of RSV-induced tumors, Immunogenetics 5 (1977) 333–343.
[11] Collins W.M., Heinzelmann E.W., Corbett A.C., Zsigray R.M., Dunlop W.R.,
Rous sarcoma regression in seven highly inbred lines of White Leghorns, Poult.
Sci. 59 (1980) 1172–1177.
[12] Collins W.M., Brown D.W., Ward P.H., Dunlop W.R., Briles W.E., MHC and
non-MHC genetic inﬂuences on Rous sarcoma metastasis in chickens, Immuno-
genetics 22 (1985) 315–321.
[13] Collins W.M., Dunlop W.R., ZsigrayR.M., Briles R.W., Fite R.W., Metastasis of
Rous sarcoma tumors in chickens is inﬂuenced by the major histocompatibility
(B) complex and sex, Poult. Sci. 65 (1986) 1642–1648.
[14] Cutting J.A., Watanabe D.H., Strebel F.R., McBride R.A., Complementing
MHC- and non-MHC-linked genes and resistance to avian sarcoma virus-
inducedtumoursin inbredlines of chickens, J. Immunogenet.8 (1981)215–223.
[15] Dambrine G., Millet N., Boyer J.P., Coudert F., Cauchy L., Immunog´ en´ etique
et r´ esistance au d´ eveloppement des sarcomes aviaires, Sci. Tech. Anim. Lab. 11
(1986) 15–24.
[16] Gebriel G.M., Nordskog A.W., Genetic linkage of subgroup C Rous sarcoma
virus-induced tumour expression in chickens to the IR-GAT locus of the B com-
plex, J. Immunogenet. 10 (1983) 231–235.
[17] Gilmour D.G., Collins W.M., Fredericksen T.L., Auclair B., Clark K.K.,
Urban W.E. Jr., Inﬂuence of non-MHC T lymphocyte alloantigens on regression
of Rous sarcomas in the chicken, Immunogenetics 17 (1983) 43–54.
[18] Gilmour D.G., Collins W.M., Fredericksen T.L., Urban W.E. Jr, Ward P.F.,
DiFronzo N.L., Genetic interaction between non-MHC T- and B-cell alloanti-
gens in response to Rous sarcomas in chickens, Immunogenetics23 (1986) 1–6.
[19] Groeneveld E., PEST User’s Manual, University of Illinois, Urbana, 1990.
[20] Groeneveld E., VCE User’s Manual, Neustadt, Germany, 1995.
[21] GylesN.R., BrownC.J., Selectionin chickensforretrogressionoftumorscaused
by Rous sarcoma virus, Poult. Sci. 50 (1971) 901–905.
[22] Gyles N.R., Miley J.L., Brown C.J., Size, score and speed of development of
tumors in chickens in response to subcutaneousinoculations with Rous sarcoma
virus, Poult. Sci. 46 (1967) 789–795.
[23] Gyles N.R., Johnson L.W., Brown C.J., Whitﬁll C.E., Heritabilitiesof regression
and progressionof Rous sarcomasin the chicken,Poult. Sci. 61 (1982)835–841.
[24] Heinzelmann E.W., Clark K.K., Collins W.M., Briles W.E., Host age and major
histocompatibility genotype inﬂuence on Rous sarcoma regression in chickens,
Poult. Sci. 60 (1981) 2171–2175.
[25] LePage K.T., Briles W.E., Kopti F., Taylor R.L. Jr, Nonmajor histocompatibility
complex alloantigen eﬀects on the fate of Rous sarcomas, Poult. Sci. 79 (2000)
343–348.80 M.-H. Pinard-van der Laan et al.
[26] LePage K.T., Miller M.M., Briles W.E., Taylor R.L. Jr., Rfp-Y genotype aﬀects
the fate of Rous sarcomas in B2B5 chickens, Immunogenetics 51 (2000) 751–
754.
[27] McBride R.A., Cutting J.A., Schierman L.W., Strebel F.R., Watanabe D.H.,
MHC gene control of growth of avian sarcoma virus-induced tumours in chick-
ens: a study on the role of virus strains, J. Immunogenet. 8 (1981) 207–214.
[28] Medarova Z., Briles W.E., Taylor R.L. Jr., Alloantigen system L aﬀects the out-
come of Rous sarcomas, Exp. Biol. Med. 227 (2002) 158–163.
[29] Meuwissen T.H.E., Luo Z., Computing inbreeding coeﬃcient in large popula-
tions, Genet. Sel. Evol. 24 (1992) 305–313.
[30] Meyer K., Restricted maximum likelihood to estimate variance components for
animal models with several random eﬀects using a derivative-free algorithm,
Genet. Sel. Evol. 21 (1989) 317–340.
[31] Pinard-van der Laan M.-H., Siegel P.B., Lamont S.J., Lessons from selection
experimentsonimmuneresponseinthechicken,Poult.AvianBiol.Rev.9(1998)
125–141.
[32] Plachy J., Korec E., Hlozanek I., Zdenkova E., Eﬀect of the expression of an
endogenousviral gene on the growth of tumoursinduced by Rous sarcoma virus
in chickens, Folia Biol. (Praha) 31 (1985) 235–240.
[33] Plachy J., Benda V., Location of the gene responsible for Rous sarcoma regres-
sion in the B-F region of the B complex (MHC) of the chicken, Folia Biol.
(Praha) 27 (1981) 363–368.
[34] SAS   Institute, SAS  /STAT User’s Guide, Version 6, Fourth edn., SAS   Insti-
tute Inc., Cary, NC, USA, 1989.
[35] SAS   Institute, Procedure Guide, Version 6, Third edn., SAS Institute Inc.,
Cary, NC, USA, 1990.
[36] SchatK.A., DaviesC.J., Viraldiseases, in: AxfordR.F.E., Bishop S.C., Nicholas
F.W., Owen J.B. (Eds.), Breeding for disease resistance in farm animals, 2nd
edn., CAB International, 2000, pp. 271–300.
[37] Senseney H.L., Briles W.E., Abplanalp H., Taylor R.L. Jr, Allelic complemen-
tation between MHC haplotypes B(Q) and B17 increases regression of Rous
sarcomas, Poult. Sci. 79 (2000) 1736–1740.
[38] Schierman L.W., Collins W.M., Inﬂuence of the major histocompatibility com-
plex on tumor regression and immunity in chickens, Poult. Sci. 66 (1987) 812–
818.
[39] Schierman L.W., Watanabe D.H., McBride R.A., Genetic control of Rous sar-
comaregressionin chickens: linkagewiththe majorhistocompatibilitycomplex,
Immunogenetics5 (1977) 325–332.
[40] Thoraval P., Afanassieﬀ M., Bouret D., Luneau G., Esnault E., Goto R.M.,
Chauss´ e A.-M., Zoorob R., Soubieux D., Miller M.M., Dambrine G., Role
of nonclassical class I genes of the chicken major histocompatibility complex
Rfp-Y locus in transplantation immunity, Immunogenetics, in press.Selection for resistance to Rous sarcoma 81
[41] Urban W.E. Jr, Zervas N.P., Collins W.M., Buck R.W., Aeed P.A., Briles W.E.,
Estimates of heritability of response to Rous sarcomas of chickens, Poult. Sci.
64 (1985) 1405–1410.
[42] Vallejo R.L., Pharr G.T., Liu H.C., Cheng H.H., Witter R.L., Bacon L.D., Non-
association between Rfp-Y major histocompatibility complex-like genes and
susceptibility to Marek’s disease virus-induced tumors in 6(3)x7(2) intercross
chickens, Anim. Genet. 28 (1997) 331–337.
[43] Wakenell P.S., Miller M.M., Goto R.M., Gauderman W.J., Briles W.E., Asso-
ciation between the Rfp-Y haplotype and the incidence of Marek’s disease in
chickens, Immunogenetics44 (1996) 242–245.
To access this journal online:
www.edpsciences.org